GlassScriptPhysician profile
Jared P Higley
NPI 1790163467
$8,597.83
in general payments reported to CMS, 2019-2025
36 companies · $1,148 in 2025
The $1,148 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.29 · 2020: $676 · 2021: $1,933 · 2022: $2,865 · 2023: $1,278 · 2024: $640 · 2025: $1,148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,492 · Travel and Lodging: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,492.26 |
| Travel and Lodging | $573.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,644.20 | 2020-2025 | |
| Boston Scientific Corporation | $848.80 | 2020-2025 | Ams 700 Cxr Rte Kit, Lithoclast, Rezum Generator |
| Valencia Technologies Corporation | $647.46 | 2023-2024 | Ecoin Device Kit |
| Teleflex LLC | $639.18 | 2021-2025 | Barrigel |
| Procept Biorobotics Corporation | $622.40 | 2021-2025 | Aquabeam System |
| Axonics, INC. | $548.31 | 2020-2024 | Axonics |
| Astellas Pharma US INC | $452.02 | 2020-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $369.10 | 2021-2024 | |
| Medtronic, INC. | $259.03 | 2023-2025 | Interstim |
| Novartis Pharmaceuticals Corporation | $195.89 | 2024-2025 | |
| Pfizer INC. | $189.01 | 2020-2022 | |
| Palette Life Sciences, INC. | $166.03 | 2022 | |
| Myovant Sciences INC. | $125.59 | 2021-2022 | |
| Janssen Biotech, INC. | $107.43 | 2019-2020 | |
| Verity Pharmaceuticals INC. | $92.04 | 2023-2025 | Trelstar, Tlando |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $74.27 | 2023-2025 | Jelmyto |
| Blue Earth Diagnostics | $67.95 | 2022-2023 | |
| Laborie Medical Technologies Corp. | $63.19 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Intuitive Surgical, INC. | $51.35 | 2023 | Da Vinci Surgical System |
| Foundation Medicine, INC. | $43.75 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $41.67 | 2019-2022 | |
| Cook Medical LLC | $40.58 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $39.67 | 2020-2024 | Keytruda |
| Urovant Sciences INC | $31.00 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $28.09 | 2021-2022 | |
| Novo Nordisk INC | $24.91 | 2024 | Rivfloza |
| Innovation Technologies INC | $24.21 | 2023 | Irrisept |
| Antares Pharma, INC. | $23.53 | 2023 | Xyosted, Nocdurna, Tlando |
| Amgen INC. | $21.57 | 2021 | |
| Clarus Therapeutics INC. | $21.00 | 2021 | |
| Myriad Genetic Laboratories, INC. | $20.22 | 2021 | |
| Travere Therapeutics, INC. | $18.01 | 2021 | |
| Sumitomo Pharma America, INC. | $17.12 | 2025 | Gemtesa |
| Ultragenyx Pharmaceutical INC. | $14.82 | 2021 | |
| Becton, Dickinson and Company | $12.58 | 2019 | |
| Allergan, INC. | $11.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Higley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.